Fig. 3 | British Journal of Cancer

Fig. 3

From: Using prognostic and predictive clinical features to make personalised survival prediction in advanced hepatocellular carcinoma patients undergoing sorafenib treatment

Fig. 3

a, b. Survival and calibration plots for all patients combined. (a) Kaplan–Meier survival curves according to the risk categories as defined by the sorafenib model and (b) calibration plots of observed KM curves (solid line) and model-predicted mean survival curve (dashed line). Risk tables for both graphs shown below each figure

Back to article page